Consensus P10, Inc.

Equities

PX

US69376K1060

Market Closed - Nyse 04:00:02 2024-05-20 pm EDT 5-day change 1st Jan Change
8.17 USD -0.73% Intraday chart for P10, Inc. -1.68% -20.06%

Evolution of the average Target Price on P10, Inc.

Price target over the last 5 years

History of analyst recommendation changes

05e0140aa860baf5.z7ER6jP67Yap9PkGWjPX2aLtZsyznSZGbmnMXpH4b6E.q-BdnAbD2enEoMxOO3qzk_ekBKfk1U1wPgyFJ_67Jumo0EWbR4CCs8-ktA~057081faff75dd138241d401d78b080c
Oppenheimer Adjusts P10 Price Target to $12 From $11, Maintains Outperform Rating MT
Barclays Adjusts Price Target on P10 to $9.50 From $14, Maintains Overweight Rating MT
Morgan Stanley Downgrades P10 to Equalweight From Overweight, Price Target is $9 MT
Oppenheimer Adjusts P10 Price Target to $11 From $17, Maintains Outperform Rating MT
JPMorgan Downgrades P10 to Neutral From Overweight, Cuts Price Target to $9.50 From $15.50 MT
Keefe Bruyette & Woods Downgrades P10 to Market Perform From Outperform, Adjusts Price Target to $10 From $12 MT
Oppenheimer Adjusts P10 Price Target to $17 From $15, Maintains Outperform Rating MT
Stephens Trims Price Target on P10 to $15 From $16, Keeps Overweight Rating MT
UBS Adjusts P10 Price Target to $13.50 From $14.50, Maintains Buy Rating MT
Morgan Stanley Adjusts Price Target on P10 to $13 From $14, Maintains Overweight Rating MT
Oppenheimer Trims P10's Price Target to $15 From $16, Keeps Outperform Rating MT
UBS Adjusts P10 Price Target to $14.50 From $12, Maintains Buy Rating MT
Morgan Stanley Adjusts Price Target on P10 to $14 From $13, Maintains Overweight Rating MT
Stephens Raises Price Target on P10 to $16 From $14, Maintains Overweight Rating MT
Oppenheimer Adjusts P10 Price Target to $16 From $17, Maintains Outperform Rating MT
Barclays Adjusts P10 Price Target to $15 From $14, Maintains Overweight Rating MT
Oppenheimer Adjusts P10 Price Target to $17 From $16, Maintains Outperform Rating MT
Oppenheimer Trims P10's Price Target to $16 From $17, Maintains Outperform Rating MT
UBS Trims P10's Price Target to $12 From $13, Maintains Buy Rating MT
Oppenheimer Raises P10's Price Target to $17 From $15, Keeps Outperform Rating MT
Morgan Stanley Adjusts P10 Price Target to $13 From $14, Maintains Overweight Rating MT
UBS Adjusts Price Target on P10 to $13 From $14, Maintains Buy Rating MT
Keefe, Bruyette & Woods Adjusts Price Target on P10 to $15 From $16, Maintains Outperform Rating MT
JPMorgan Adjusts P10's Price Target to $15 From $16, Keeps Overweight Rating MT
Oppenheimer Adjusts P10's Price Target to $17 From $15, Maintains Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
8.17 USD
Average target price
10 USD
Spread / Average Target
+22.40%
High Price Target
12 USD
Spread / Highest target
+46.88%
Low Price Target
9 USD
Spread / Lowest Target
+10.16%

Consensus detail

Consensus revision (last 18 months)

Analysts covering P10, Inc.

Oppenheimer
Barclays
Morgan Stanley
JPMorgan Chase
Keefe, Bruyette & Woods
Stephens Inc.
UBS
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW